{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:36:48Z","timestamp":1773175008718,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.urology.2019.12.041","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T11:28:38Z","timestamp":1581938918000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Fate of Pediatric Renal Angiomyolipoma During mTOR Inhibitor Treatment in Tuberous Sclerosis Complex"],"prefix":"10.1016","volume":"139","author":[{"given":"Charlotte Q.","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2019.12.041_bib0001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-017-3806-1","article-title":"The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma","volume":"33","author":"Bissler","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.urology.2019.12.041_bib0002","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2019.12.041_bib0003","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/dmcn.13352","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","author":"Amin","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.urology.2019.12.041_bib0004","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urology.2019.12.041_bib0005","doi-asserted-by":"crossref","first-page":"e0497","DOI":"10.1097\/MD.0000000000010497","article-title":"An update on recent developments in rupture of renal angiomyolipoma","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.urology.2019.12.041_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15586\/jkcvhl.2017.97","article-title":"The risks of renal angiomyolipoma: reviewing the evidence","volume":"4","author":"Seyam","year":"2017","journal-title":"J Kidney Cancer VHL"},{"key":"10.1016\/j.urology.2019.12.041_bib0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2019.12.041_bib0008","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2019.12.041_bib0009","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","article-title":"Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex","volume":"17","author":"MacKeigan","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.urology.2019.12.041_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.urology.2019.12.041_bib0011","unstructured":"Afinitor. In: Package Insert: Novartis Pharmaceuticals Corporation, 2019"},{"key":"10.1016\/j.urology.2019.12.041_bib0012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2019.12.041_bib0013","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.juro.2016.09.082","article-title":"Pediatric renal angiomyolipomas in tuberous sclerosis complex","volume":"197","author":"Warncke","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.12.041_bib0014","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.juro.2007.07.058","article-title":"Urological counseling and followup in pediatric tuberous sclerosis complex","volume":"178","author":"Castagnetti","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2019.12.041_bib0015","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ndt\/gfu013","article-title":"The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1","volume":"29","author":"Kingswood","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.urology.2019.12.041_bib0016","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s11255-014-0701-6","article-title":"Association between the growth rate of renal cysts\/angiomyolipomas and age in the patients with tuberous sclerosis complex","volume":"46","author":"Tsai","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2019.12.041_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201005","article-title":"Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis","volume":"13","author":"Bissler","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2019.12.041_bib0018","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/iju.13428","article-title":"Intermittent everolimus administration for renal angiomyolipoma associated with tuberous sclerosis complex","volume":"24","author":"Hatano","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2019.12.041_bib0019","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jim-2018-000865","article-title":"Continuous low-dose everolimus shrinkage tuberous sclerosis complex-associated renal angiomyolipoma: a 48-month follow-up study","volume":"67","author":"Wei","year":"2019","journal-title":"J Investig Med"},{"key":"10.1016\/j.urology.2019.12.041_bib0020","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/TP.0b013e31824bf1f0","article-title":"Sirolimus-associated testicular toxicity: detrimental but reversible","volume":"93","author":"Rovira","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.urology.2019.12.041_bib0021","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ckj\/sfx094","article-title":"Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex","volume":"10","author":"Buj Pradilla","year":"2017","journal-title":"Clin Kidney J"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520301758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520301758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:02:32Z","timestamp":1758765752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520301758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":21,"alternative-id":["S0090429520301758"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2019.12.041","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fate of Pediatric Renal Angiomyolipoma During mTOR Inhibitor Treatment in Tuberous Sclerosis Complex","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2019.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}